Recent News
September 04, 2018 Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia
September 04, 2018 Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology
August 29, 2018 Aduro Biotech to Present at the 20th Annual H.C. Wainwright Global Investment Conference
Careers
Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?
